The Ashkenazi-Centric G334R Variant of <i>TP53</i> is Severely Impaired for Transactivation but Retains Tumor Suppressor Function in a Mouse Model

David C. Stieg(The Wistar Institute), Maureen E. Murphy(Fox Chase Cancer Center)
Molecular and Cellular Biology
November 8, 2024
Cited by 2


Related Papers